Parkinsons News: 273 headlines
Watch this Muhammad Ali Parkinson's video!
Celebrity Fight Night Video
Presented by MD Health Channel

Celebrity Fight Night:
122 Photo-Slideshow
CLICK HERE
Watch Muhammad Ali fight clips on this Parkinson's video!

Sources used by our Parkinsons News Channel Research Team:
The New York Times, CNN, FOX, CBS, BBC, Mayo Clinic, Johns Hopkins Medicine, UCLA Medical Center, National Institute of Health, Stanford Hospital, Memorial Sloan- Kettering, Yale Cancer Center, Massachusetts General Hospital, Brigham and Women's Hospital, University of Michigan, M. D. Anderson Cancer Center, National Institute of Health, American Cancer Association, NBC, Reuters News, American College of Cardiology, Journal of the American Medical Association & 100's more

Links
Barrow Neurological Institute

Archives

This page is powered by Blogger. Isn't yours?

Monday

 
Stem Cell Work Shows Promise and Risks: Parkinson's Treatment Tried in Rats Reduced Symptoms but Caused Tumors - Washington Post
Nerve cells grown from human embryonic stem cells and injected into the brains of rats with a syndrome mimicking Parkinson's disease significantly reduced the animals' symptoms, but the treatment also caused tumors in the rodents' brains, scientists reported yesterday.

Researchers said the work showed both the potential benefits and risks of human embryonic stem cells, which have been highly touted for their capacity to replace diseased tissue but are controversial because they are derived through the destruction of human embryos.

"The behavioral data validate the utility of the approach. But it also raises a cautionary flag and says we are not ready for prime time yet," said lead researcher Steven A. Goldman, a professor of neurology and neurosurgery at the University of Rochester Medical Center.

Goldman said he suspected that with modest changes in technique, researchers will be able to keep the benefits of the treatment while eliminating or reducing the chances of getting the cancerlike growths. But he conceded that much more basic research would have to be done before scientists -- or regulators -- were likely to be convinced of the approach's safety.MORE- Washington Post